Earnings call analysis

UnitedHealth Group (UNH) Q3 2026 Earnings Call: Guidance and Outlook

The company provided updated full-year 2026 adjusted EPS guidance of at least $20.50. Management also reaffirmed their long-term growth target of 13% to 16% and provided insights into 2027 expectations.

About UnitedHealth Group. UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services.

Call date

Oct 13, 2026

Sentiment score

+25 Balanced

Management tone, -100 to +100

Sentiment change

-20

vs Q2 2026 call

Sector

Health Care, Health Care Providers and Services

Next report

Jan 20, 2027

View calendar

Quarterly guidance

Quarterly guidance: No specific quarterly guidance was provided for Q4 2026.

Annual guidance

Adjusted EPS: At least $20.50
Debt-to-cap ratio: Approach 40% by year-end

Outlook

Medical Trends: Costs remain elevated, particularly in specialty pharmacy and acute care, though trends are showing signs of stabilization.
Medicaid: 2026 is viewed as a trough year for core margins, with expectations for improvement in 2027 and a return to target margins by 2028.
Medicare Advantage: The company is prioritizing high-value HMO and special needs plans to drive durable growth.
Optum Health: The business is on a multiyear journey to reach a 6% to 8% margin range by 2028.
AI Strategy: The company is aggressively integrating AI to reduce administrative friction, improve clinician productivity, and enhance payment integrity.
Commercial Business: Performance is stabilizing, though the company remains mindful of trend pressures and the impact of the No Surprises Act.

Sources and method

Dombey's summary of the UnitedHealth Group Q3 2026 earnings call held Oct 13, 2026, written from the call itself. Every figure on this page was checked against what was said on the call, and quoted lines are management's own words; we do not add estimates or prices. The tone score is our read of management's wording, guidance and answers. Check figures against the company's SEC filings before acting. This is research, not investment advice.

Updated Nov 8, 2026. All earnings call analyses

Research access

Research published before the catalyst, kept on the record after it.

Public ArchiveComplimentaryA starting point for exploring our independent perspective on global equities through published executive theses and publicly available research.Read public research Standard Access$6.67 / monthOngoing catalyst coverage and the complete public-research archive, for readers who want to follow forthcoming events and revisit the firm's published thinking.Start Standard Access RecommendedFounding Membership$1,200 / yearInstitutional access to the complete research suite, proprietary models and execution strategy.Become a Founding Member